Résumé :
|
[BDSP. Notice produite par INIST-CNRS H1R0xlFX. Diffusion soumise à autorisation]. Objectives. This study was designed to assess sociodemographic and medical insurer factors associated with receipt of highly active antiretroviral therapy (HAART). Methods. Patients included (n=959) were enrolled in the Johns Hopkins HIV Clinic after April 1,1996, received>=90 days of care, and had a CD4 count>=500 cells/mm3 or HIV-1 RNA>20000 copies/mL. We assessed the associations of sociodemographic factors and medical insurance with receipt of HAART, stratified by 2 time periods (April 1996 through March 1997 versus April 1997 through March 1999). Results. HAART was more likely to be used in patients who were>39 years. White, had CD4 counts
|